Yumesartan Tablets 20 mg (Olmesartan Medoxomil)
Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Yuyu Pharmaceutical Co., Ltd.
MFDS item code 201903231 · Approved 2019.05.20
This product's status changed to Expired on 2024.05.20. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension
Essential hypertension is a condition where blood pressure is consistently high without a specific cause. This medication lowers blood pressure and dilates blood vessels, reducing the burden on the heart. Regular use can facilitate blood pressure control and aid in the prevention of complications. Dosage instructions will be provided according to the patient's condition, and it is important to treat this condition alongside lifestyle modifications. Regular blood pressure monitoring while continuously taking this medication can lead to positive outcomes. This medication is used for the treatment of essential hypertension.
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is needed, the dose may be increased to a maximum of 40mg once daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum after approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be coadministered with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended to initiate treatment at a low dose while carefully monitoring their condition. <Elderly patients> No dose adjustment is required when administering this drug to elderly patients aged 65 years or older. No overall differences in efficacy or safety have been observed between elderly and younger patients; however, a more pronounced response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is required for patients with mild hepatic impairment. For patients with moderate hepatic impairment, the recommended initial dose is 10mg once daily, which may be increased to a maximum of 20mg once daily. Use is not recommended in patients with severe hepatic impairment because there is no experience with its use in these patients.
Safety and efficacy in children have not been established.
This medication can cause serious harm or death to the fetus or newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Individuals with allergies to any components of this medication, pregnant or breastfeeding women, patients undergoing kidney dialysis, patients with severe liver impairment, patients with obstructive biliary disorders, patients with lactose intolerance, specific diabetic patients, and patients with moderate to severe renal impairment should not use this medication. Special caution is required when using this medicine in patients with reduced blood volume or sodium, severe heart failure, weak renal function, renovascular hypertension, those at risk for hyperkalemia, those with aortic or mitral stenosis, and patients with primary aldosteronism, and their conditions should be closely monitored at the start of treatment. Dizziness may occur while taking this medication; therefore, it is advisable to avoid hazardous activities such as operating dangerous machinery or driving. Clinical trials and post-marketing studies have shown this medication to be relatively safe, but side effects such as dizziness, headache, back pain, indigestion, chest pain, peripheral edema, and hyperkalemia may occur. Chronic diarrhea and weight loss resembling chronic malabsorption syndrome may occur, so if these symptoms arise during treatment, the patient should consult a physician immediately. Taking this medication together with potassium-sparing diuretics or potassium supplements can dangerously elevate serum potassium levels, so regular blood tests to monitor potassium levels are necessary in such cases. When administered with other antihypertensive agents, the blood pressure-lowering effect may increase, so caution is required, and it is not recommended to use lithium preparations concomitantly due to the risk of lithium toxicity. Combining this medication with non-steroidal anti-inflammatory drugs may worsen renal function, so renal function should be monitored regularly, and adequate hydration is essential. During pregnancy, there is a severe risk to the fetus, so this medication should not be taken if planning to become pregnant or during pregnancy, and nursing mothers should also discontinue breastfeeding or consult a doctor if taking this medication, as adverse reactions may occur in infants. Safety in children has not been established, and elderly patients may require dose adjustments due to increased drug concentrations in the body. Overdose may lead to hypotension, palpitations, bradycardia, etc., and appropriate treatment is required depending on the symptoms.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 to 25 degrees Celsius.
White, round film-coated tablets
Domestic - 30 tablets/bottle, Domestic - 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Yuyu Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
JW Pharmaceutical Corp.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
DongKook Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.